Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

13.81

-0.22 (-1.57%)

At close: May 14, 2026, 4:00 PM EDT

13.81

0.00 (0.00%)

After-hours: May 14, 2026, 4:10 PM EDT

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	34.93	32.3	37.23	85.39	43.99	57.21
Short-Term Investments	128.85	156.57	210.95	284.52	205.24	186.8
Cash & Short-Term Investments	163.77	188.86	248.19	369.91	249.23	244
Cash Growth	-15.31%	-23.90%	-32.91%	48.42%	2.14%	-36.89%
Accounts Receivable	7.81	6.88	6.65	8.61	20.32	23.58
Other Current Assets	6.83	8.59	44.62	44.27	42.16	51.44
Total Current Assets	178.41	204.34	299.45	422.79	311.71	319.02
Net Property, Plant & Equipment	69.55	72.94	73.35	34.71	29.75	10.65
Long-Term Investments	63.24	-	-	-	29.29	108.42
Other Long-Term Assets	3.5	3.45	3.45	4.77	4.66	0.7
Total Assets	314.7	280.73	376.25	462.28	375.41	438.79
Accounts Payable	4.36	1.95	8	4.1	6	9.54
Accrued Expenses	6.86	12.75	13.55	18.34	20.94	22.43
Current Portion of Leases	3.76	3.15	1.52	5.28	2.89	4.2
Other Current Liabilities	31.46	30.71	34.46	35.08	-	-
Total Current Liabilities	46.44	48.56	57.54	62.79	29.83	36.17
Long-Term Leases	52.78	54.76	53.94	21.24	22.37	1.13
Other Long-Term Liabilities	98.9	112.68	136.36	161.52	1.88	2.06
Total Long-Term Liabilities	151.68	167.44	190.3	182.75	24.25	3.19
Total Liabilities	198.12	216.02	247.84	245.54	54.08	39.36
Common Stock	0.29	0.21	0.21	0.21	0.21	0.2
Additional Paid-in Capital	546.99	469.77	451.34	424.69	398.03	351.03
Accumulated Other Comprehensive Income	-0.73	-0.34	0.3	-1.17	-3.72	-0.38
Retained Earnings	-429.96	-404.93	-323.04	-207	-73.18	48.58
Shareholders' Equity	116.59	64.72	128.81	216.74	321.33	399.43
Total Liabilities & Equity	314.7	280.73	376.65	462.28	375.41	438.79
Total Debt	56.54	57.9	55.47	26.51	25.26	5.33
Net Cash (Debt)	107.24	130.96	192.72	343.4	223.97	238.67
Net Cash Growth	-18.12%	-32.05%	-43.88%	53.32%	-6.16%	-36.95%
Net Cash Per Share	4.27	6.14	9.11	16.38	10.87	11.83
Book Value	116.59	64.72	128.81	216.74	321.33	399.43
Book Value Per Share	4.64	3.03	6.09	10.34	15.60	19.80
Tangible Book Value	116.59	64.72	128.81	216.74	321.33	399.43
Tangible Book Value Per Share	4.64	3.03	6.09	10.34	15.60	19.80

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q